AIM Vaccine Confirms Stable Share Capital and Meets Public Float Requirement in October 2026 Filing

Bulletin Express
11/03

AIM Vaccine Co., Ltd. (AIM Vaccine) reported no changes in its share structure for the month ended 31 October 2026, according to the company’s monthly return submitted to Hong Kong Exchanges and Clearing on 3 November 2026.

Registered Capital • H Shares: 507.67 million shares at RMB 1 par value each, unchanged from the prior month. • Domestic Shares: 718.89 million shares at RMB 1 par value each, also unchanged. • Total registered share capital remained RMB 1.23 billion.

Issued Shares and Public Float • Issued H Shares (stock code 06660) totaled 507.67 million, with no treasury shares outstanding. • Issued Domestic Shares were steady at 718.89 million. • The company confirmed compliance with the Hong Kong Main Board’s minimum 25% public-float requirement.

Capital Movements • No issuance, cancellation, repurchase, or conversion of shares occurred during October. • There were no outstanding share options, warrants, convertibles, or other agreements that could dilute current share capital. • The company reported no Hong Kong Depositary Receipts.

Governance Confirmation Company Secretary Liu Ling affirmed that all listing rule obligations and regulatory requirements related to the issuer’s securities continue to be satisfied.

With registered and issued share counts unchanged and full adherence to public-float rules, AIM Vaccine’s capital structure remained stable through October 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10